Protease/NN
treatment/NN
of/IN
nuclear/JJ
extracts/NNS
distinguishes/VBZ
between/IN
class/NN
II/CD
MHC/NN
X1/NN
box/NN
DNA-binding/JJ
proteins/NNS
in/IN
wild-type/JJ
and/CC
class/NN
II-deficient/JJ
B/NN
cells/NNS
./.

The/DT
X/NN
box/NN
region/NN
is/VBZ
critical/JJ
for/IN
directing/VBG
the/DT
expression/NN
of/IN
class/NN
II/CD
major/JJ
histocompatibility/NN
complex/NN
genes/NNS
in/IN
B/NN
lymphocytes/NNS
./.
=====
Although/IN
several/JJ
class/NN
II/CD
promoter-specific/JJ
DNA/NN
binding/NN
factors/NNS
have/VBP
been/VBN
described/VBN
,/,
only/RB
the/DT
X/NN
box/NN
region/NN
factor/NN
,/,
RFX/NN
,/,
shows/VBZ
a/DT
genetic/JJ
correlation/NN
with/IN
class/NN
II/CD
expression/NN
,/,
being/VBG
deficient/JJ
in/IN
some/DT
B/NN
cell/NN
lines/NNS
derived/VBN
from/IN
patients/NNS
with/IN
class/NN
II-deficient/JJ
congenital/JJ
immunodeficiency/NN
./.
=====
To/TO
further/RB
evaluate/VB
the/DT
role/NN
of/IN
X/NN
box/NN
DNA-binding/JJ
proteins/NNS
in/IN
class/NN
II/CD
gene/NN
expression/NN
,/,
the/DT
role/NN
of/IN
the/DT
X/NN
box/NN
region/NN
was/VBD
examined/VBN
in/IN
both/DT
class/NN
II-positive/JJ
and/CC
-negative/JJ
lymphoid/JJ
cells/NNS
./.
=====
In/IN
addition/NN
to/TO
the/DT
wild-type/JJ
B/NN
cell/NN
line/NN
Raji/NN
,/,
two/CD
class/NN
II/CD
transcriptional/JJ
mutant/JJ
cell/NN
lines/NNS
,/,
SJO/NN
and/CC
RJ2.2.5/NN
,/,
and/CC
Jurkat/NN
,/,
a/DT
class/NN
II/CD
negative/JJ
T/NN
cell/NN
line/NN
,/,
were/VBD
examined/VBN
./.
=====
In/IN
contrast/NN
to/TO
wild-type/JJ
B/NN
cells/NNS
,/,
neither/DT
of/IN
the/DT
class/NN
II/CD
mutant/JJ
cell/NN
lines/NNS
could/MD
use/VB
the/DT
X/NN
box/NN
region/NN
to/TO
direct/VB
the/DT
expression/NN
of/IN
a/DT
transiently/RB
transfected/VBN
reporter/NN
gene/NN
,/,
indicating/VBG
that/IN
the/DT
X/NN
box-dependent/JJ
transcriptional/JJ
pathway/NN
is/VBZ
defective/JJ
in/IN
these/DT
cells/NNS
./.
=====
The/DT
binding/NN
activity/NN
of/IN
the/DT
X1/NN
box/NN
DNA-binding/JJ
protein/NN
RFX/NN
was/VBD
examined/VBN
and/CC
found/VBN
to/TO
be/VB
present/JJ
in/IN
wild-type/JJ
B/NN
cells/NNS
and/CC
the/DT
mutant/JJ
RJ2.2.5/NN
but/CC
was/VBD
absent/JJ
in/IN
SJO/NN
and/CC
Jurkat/NN
./.
=====
However/RB
,/,
other/JJ
X1/NN
box-specific/JJ
activities/NNS
were/VBD
detected/VBN
in/IN
all/DT
these/DT
cell/NN
lines/NNS
./.
=====
To/TO
determine/VB
whether/IN
these/DT
different/JJ
X1/NN
box/NN
activities/NNS
represented/VBD
distinct/JJ
DNA/NN
binding/NN
proteins/NNS
or/CC
multimeric/JJ
forms/NNS
of/IN
the/DT
same/JJ
factor/NN
(/(
s/NNS
)/)
,/,
protease/NN
treatment/NN
of/IN
the/DT
crude/JJ
nuclear/JJ
extracts/NNS
followed/VBN
by/IN
DNA-binding/JJ
assays/NNS
were/VBD
carried/VBN
out/RP
and/CC
demonstrated/VBD
that/IN
B/NN
cell/NN
extracts/NNS
contain/VBP
at/IN
least/JJS
two/CD
X1-specific/JJ
factors/NNS
./.
=====
One/CD
of/IN
these/DT
cleaved/VBN
products/NNS
(/(
band/NN
1/CD
pk/NN
)/)
correlates/VBZ
with/IN
RFX/NN
activity/NN
./.
=====
A/DT
similar/JJ
comparison/NN
with/IN
protease-treated/JJ
extracts/NNS
prepared/VBN
from/IN
Jurkat/NN
cells/NNS
demonstrated/VBD
the/DT
presence/NN
of/IN
the/DT
band/NN
1pk/NN
activity/NN
despite/IN
an/DT
absence/NN
of/IN
the/DT
native/JJ
RFX/NN
activity/NN
./.
=====
In/IN
contrast/NN
,/,
protease/NN
treatment/NN
and/CC
analysis/NN
of/IN
SJO/NN
extracts/NNS
showed/VBD
no/DT
detectable/JJ
levels/NNS
of/IN
the/DT
band/NN
1pk/NN
activity/NN
./.
=====
These/DT
results/NNS
demonstrate/VBP
that/IN
multiple/JJ
X1/NN
box-specific/JJ
DNA-binding/JJ
activities/NNS
exist/VBP
in/IN
all/DT
lymphoid/JJ
cells/NNS
,/,
but/CC
the/DT
presence/NN
of/IN
an/DT
actively/RB
binding/NN
RFX/NN
species/NNS
correlates/VBZ
with/IN
class/NN
II/CD
transcription/NN
./.